Business Of Healthcare
Are pharmaceutical makers becoming outcomes companies? with AJ Ploszay, Ph.D. (GlaxoSmithKline) Brad Ansley (SPI Health)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:32:36
- More information
Informações:
Synopsis
Digital is disrupting pharmaceutical companies at their very core: product development and commercial operations. We explore this with two leaders deep in the thick of transforming this key healthcare segment . . . 10% of the overall healthcare spend in the US . . . as digital innovation destroys and recreates the industry.
